Investments
13Portfolio Exits
2Latest GT Capital News
Mar 18, 2020
Inquirer Business / 04:44 PM March 18, 2020 The Metrobank and GT Capital Holdings group on Wednesday said they stand with all Filipinos in facing the challenges brought on by COVID-19 pandemic that has sickened over 200 people in the country. “The Ty family-led companies are pledging support to manage the disruption and provide meaningful assistance to customers, employees, and partners who most need help in these difficult times,” Metrobank said in a statement. ADVERTISEMENT The banking firm said aside from the assistance already being extended to impacted customers and displaced employees, a pledge of a P200 million fund would go to initiatives directly supporting the fight against the virus. “These initiatives will be managed by the respective Foundatiowards ns of the Group and will start with efforts to produce the test kits developed by the University of the Philippines-National Institutes of Health (UP-NIH) and the purchase of Personal Protective Equipment (PPE) for frontline health workers,” Metrobank said. FEATURED STORIES
GT Capital Investments
13 Investments
GT Capital has made 13 investments. Their latest investment was in Accurant BioTech as part of their Series B on January 1, 2022.
GT Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
1/29/2022 | Series B | Accurant BioTech | $20.44M | No | 1 | |
1/11/2022 | Series C | ZhenGe Biotech | $100M | No | Cowin Capital, Goldman Sachs Asset Management, IDG Capital, Junxin Capital, LFE Capital, LYFE Capital, Novo Holdings, Qiming Venture Partners, Sofina, and Undisclosed Investors | 16 |
10/22/2021 | Private Equity | Pharma Legacy | $100M | Yes | 7 | |
8/26/2021 | Series B | |||||
8/19/2021 | Series A - II |
Date | 1/29/2022 | 1/11/2022 | 10/22/2021 | 8/26/2021 | 8/19/2021 |
|---|---|---|---|---|---|
Round | Series B | Series C | Private Equity | Series B | Series A - II |
Company | Accurant BioTech | ZhenGe Biotech | Pharma Legacy | ||
Amount | $20.44M | $100M | $100M | ||
New? | No | No | Yes | ||
Co-Investors | Cowin Capital, Goldman Sachs Asset Management, IDG Capital, Junxin Capital, LFE Capital, LYFE Capital, Novo Holdings, Qiming Venture Partners, Sofina, and Undisclosed Investors | ||||
Sources | 1 | 16 | 7 |
GT Capital Portfolio Exits
2 Portfolio Exits
GT Capital has 2 portfolio exits. Their latest portfolio exit was Novosense on April 22, 2022.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.